DIABETICMedicine
DOI:10.1111/j.1464-5491.2010.03209.x
Article: Treatment
Vegetarian diet improves insulin resistance and oxidative
stress markers more than conventional diet in subjects
with Type 2 diabetes
H. Kahleova, M. Matoulek*, H. Malinska, O. Oliyarnik, L. Kazdova, T. Neskudla, A. Skoch,
M. Hajek, M. Hill†, M. Kahle and T. Pelikanova
InstituteforClinicalandExperimentalMedicine,*CharlesUniversity,1stFacultyofMedicineand†InstituteofEndocrinology,Prague,CzechRepublic
Accepted19November2010
Abstract
Aims Theaimofthisstudywastocomparetheeffectsofcalorie-restrictedvegetarianandconventionaldiabeticdietsaloneand
incombinationwithexerciseoninsulinresistance,visceralfatandoxidativestressmarkersinsubjectswithType2diabetes.
Methods A24-week,randomized,open,paralleldesignwasused.Seventy-fourpatientswithType2diabeteswererandomly
assignedtoeithertheexperimentalgroup(n=37),whichreceivedavegetariandiet,orthecontrolgroup(n=37),which
receivedaconventionaldiabeticdiet.Bothdietswereisocaloric,calorierestricted(-500kcal⁄day).Allmealsduringthestudy
wereprovided.Thesecond12weeksofthedietwerecombinedwithaerobicexercise.Participantswereexaminedatbaseline,
12weeks and 24weeks. Primary outcomes were: insulin sensitivity measured by hyperinsulinaemic isoglycaemic clamp;
volume of visceral and subcutaneous fat measured by magnetic resonance imaging; and oxidative stress measured by
thiobarbituricacidreactivesubstances.Analyseswerebyintentiontotreat.
Results Forty-threepercentofparticipantsintheexperimentalgroupand5%ofparticipantsinthecontrolgroupreduced
diabetesmedication(P<0.001).Bodyweightdecreasedmoreintheexperimentalgroupthaninthecontrolgroup[–6.2kg
(95%CI–6.6to–5.3)vs.–3.2kg(95%CI–3.7to–2.5);interactiongroup·timeP=0.001].Anincreaseininsulinsensitivity
was significantly greater in the experimental group than in the control group [30% (95%CI24.5–39) vs. 20%
(95%CI14–25),P=0.04].Areductioninbothvisceralandsubcutaneousfatwasgreaterintheexperimentalgroupthan
inthecontrolgroup (P=0.007 andP=0.02, respectively).Plasmaadiponectinincreased(P=0.02)andleptin decreased
(P=0.02)intheexperimentalgroup,withnochangeinthecontrolgroup.VitaminC,superoxidedismutaseandreduced
glutathioneincreasedintheexperimentalgroup(P=0.002,P<0.001andP=0.02,respectively).Differencesbetweengroups
were greater after the addition of exercise training. Changes in insulin sensitivity and enzymatic oxidative stress markers
correlatedwithchangesinvisceralfat.
Conclusions A calorie-restricted vegetarian diet had greater capacity to improve insulin sensitivity compared with a
conventional diabetic diet over 24weeks. The greater loss of visceral fat and improvements in plasma concentrations of
adipokinesandoxidativestressmarkerswiththisdietmayberesponsibleforthereductionofinsulinresistance.Theadditionof
exercisetrainingfurtheraugmentedtheimprovedoutcomeswiththevegetariandiet.
Diabet. Med. 28, 549–559 (2011)
Keywords exercise, insulin resistance, oxidative stress markers, vegetarian diet, visceral fat
Introduction
Type2diabetesisonlyhalfasprevalentinvegetarianscompared
Correspondenceto:TereziePelikanovaMD,Videnska1958⁄9,14120
Prague,CzechRepublic.E-mail:terezie.pelikanova@ikem.cz withnon-vegetarians[1,2].Randomizedcontrolledintervention
studies in patients with Type2 diabetes have shown greater
Re-useofthisarticleispermittedinaccordancewiththeTermsand
weight loss, reduction in fasting plasma glucose [3], greater
Conditionssetoutathttp://wileyonlinelibrary.com/onlineopen#OnlineOpen_
Terms improvementsinHbA andfastingandpostprandiallipids[4,5],
1c
andreductionofdiabetesmedications[3–5]withvegetariandiets
(ClinicalTrialsRegistryNo;NCT00883038)
ª2011TheAuthors.
DiabeticMedicineª2011DiabetesUK 549
DIABETICMedicine VegetariandietinType2diabetes,arandomizedstudy•H.Kahleovaetal.
comparedwithmoreconventionaldietsusedtotreatdiabetes. volumeofvisceralfatandimprovingoxidativestressmarkers
Themechanismshavenotbeenfullyelucidated. thanaconventionaldiabeticdietandtherewouldbeafurther
Exercise training reduces insulin resistance by a number of enhancementofthedifferencebetweengroupsaftertheaddition
mechanisms: preferential loss of visceral fat, stimulation of ofexercisetraining.
muscle development, increased skeletal muscle insulin action,
morphological changes in muscle and improved control over
Patients and methods
hepaticglucoseproduction[6].Toourknowledge,theeffectsof
the combination of a vegetarian diet and exercise training
Subjects
comparedwithconventionaldietsincombinationwithexercise
training on insulin resistance, resting energy expenditure and Subjects with Type2 diabetes treated by oral hypoglycaemic
volumeofvisceralfatinpatientswithType2diabeteshavenot agents were recruited from February to May 2008. Inclusion
yetbeenstudied. criteriawere:Type2diabetes,age30–70years,HbA between
1c
Theaimofourstudywastocomparetheeffectsofisocaloric, 6and11%(42–97mmol⁄mol),BMIbetween25and53kg⁄m2,
calorie-restrictedvegetarianandconventionaldiabeticdietson andwillingnesstochangedietaryhabitsandfollowaprescribed
insulinresistance,volumeofvisceralfatandplasmamarkersof exercise programme. Exclusion criteria were HbA <6%
1c
oxidativestressaftera3-monthdietary-interventionphaseandto (<42mmol⁄mol)or>11%(>97mmol⁄mol),useofinsulin,
test whether the positive changes will be sustainable or even abuseofalcoholordrugs,pregnancy,lactation,orcurrentuseof
augmented after adding aerobic exercise training for an a vegetarian diet. Out of 161 patients pre-chosen by their
additional3months.Ourhypothesiswasthatavegetariandiet endocrinologists,74mettheinclusioncriteriaandgavewritten
would be more effective in reducing insulin resistance and informedconsent(Fig.1,Table1).
161 persons with T2DM were
February – May 2008
screened
87 were excluded
32 did not meet inclusion criteria
55 refused to participate
74 underwent
June 2008 randomization
37 were assiggned to 37 were assiggned to
vegetarian diet conventional diabetic diet
4 withdrew
2 withdrew owing to
2 lacked motivation
lack of motivation
2 had personal reasons
November - 35 completed 3 months 35 completed 3 months
December of diet intervention of diet intervention
2008
4 with drew owing to 2 withdrew owing to
lack of motivation lack of motivation
31 completed another 3 31 completed another 3
FFeebbrruuaarryy - months of diet and months of diet and
March 2009 exercise exercise
37 were included in the 37 were included in the
analysis analysis
FIGURE1 Enrollmentoftheparticipantsandcompletionofthestudy.T2DM,Type2diabetesmellitus.
ª2011TheAuthors.
550 DiabeticMedicineª2011DiabetesUK
Originalarticle DIABETICMedicine
Table1 Baselinecharacteristicsofthestudypopulation
Characteristic Experimentalgroup(n=37) Controlgroup(n=37)
Age(years) 54.6(cid:2)7.8 57.7(cid:2)4.9
Sex(%)
Male 17(46) 18(49)
Female 20(54) 19(51)
Smokers(%) 9(24) 5(14)
Weight(kg) 101.1(cid:2)17.1 100.8(cid:2)17.8
BMI(kgm)2) 35.1(cid:2)6.1 35.0(cid:2)4.6
Waistcircumference(cm) 113.7(cid:2)11.2 113.8(cid:2)13.1
Bloodpressure(mmHg)
Systolic 133(cid:2)16 130(cid:2)13
Diastolic 85(cid:2)13 84(cid:2)8
Restingheartrate(beatsmin)1) 73(cid:2)7 74(cid:2)10
Volumeofabdominalfat(ml)
Visceralfat 4266(cid:2)1994 4275(cid:2)1954
Subcutaneousfat 8140(cid:2)3847 8110(cid:2)2739
Metabolicclearancerateofglucose(mlkg)1min)1) 2.29(cid:2)0.8 2.24(cid:2)0.8
Bloodbiomarkers
Cholesteroltotal(mmoll)1) 4.4(cid:2)0.8 4.2(cid:2)0.9
LDLcholesterol(mmoll)1) 2.54(cid:2)0.6 2.57(cid:2)0.8
HDLcholesterol(mmoll)1) 1.07(cid:2)0.3 1.09(cid:2)0.2
Triglycerides(mmoll)1) 2.1(cid:2)0.9 2.1(cid:2)0.9
Homocysteine(lmoll)1) 12.5(cid:2)4.5 13.1(cid:2)3.7
Freefattyacids(mmoll)1) 0.54(cid:2)0.3 0.58(cid:2)0.4
Fibrinogen(gl)1) 4.3(cid:2)1.3 3.9(cid:2)1.1
Fastingplasmaimmunoreactiveinsulin(nmoll)1) 15.4(cid:2)8.0 14.8(cid:2)9.3
FastingplasmaC-peptide(mIUl)1) 1.3(cid:2)0.6 1.4(cid:2)0.6
Fastingplasmaglucose(mmoll)1) 9.5(cid:2)2.8 9.5(cid:2)2.4
HbA [DCCT,%;(IFCC,mmol⁄mol)] 7.6(cid:2)1.4(60(cid:2)14) 7.7(cid:2)1.2(61(cid:2)12)
1c
hsCRP(mgl)1) 5.6(cid:2)6.3 5.5(cid:2)4.8
Adiponectintotal(lgml)1) 6.7(cid:2)3.8 6.8(cid:2)3.1
HMWadiponectin(lgml)1) 4.0(cid:2)2.0 4.0(cid:2)2.6
Leptin(pm) 1100(cid:2)1121 1112(cid:2)946
Resistin(ngml)1) 9.47(cid:2)5.8 9.82(cid:2)4.6
VitaminC(lgmmol)1) 80.7(cid:2)22.0 81.3(cid:2)24.2
Superoxidedismutase(Uml)1) 4.7(cid:2)2.2 4.7(cid:2)1.1
Catalase(H O .min)1mg)1) 679(cid:2)189 659(cid:2)198
2 2
TBARS(lmoll)1) 1.7(cid:2)0.6 1.7(cid:2)0.4
Reducedglutathione(mmoll)1) 2.7(cid:2)0.9 2.7(cid:2)0.6
Glutathionereductase(mmolNADPHmin)1mg)1) 259(cid:2)97 262(cid:2)94
Glutathioneperoxidase(mmolGSHmin)1mg)1) 631(cid:2)147 627(cid:2)125
Glutathionetransferase(mmolGSHmin)1mg)1) 32.2(cid:2)11.5 34.1(cid:2)9.1
Medications
Oralhypoglycaemicagents(%)
Metformin 29(78) 28(76)
Sulphonylurea 20(54) 13(35)
Thiazolidinedione 7(19) 5(14)
Other 8(22) 3(8)
Lipid-loweringtherapy(%) 22(59) 16(43)
Anti-hypertensivetherapy(%) 25(68) 22(59)
Indirectcalorimetry
Respiratoryquotient 0.77(cid:2)0.1 0.76(cid:2)0.1
Restingenergyexpenditure(REE)(kcalday)1) 1792(cid:2)317 1727(cid:2)322
REE(%ofpredictedvalue) 111.9(cid:2)49.4 106.5(cid:2)35
Fastingoxidationofcarbohydrates(mgkg)1min)1) 0.73(cid:2)0.66 0.73(cid:2)0.66
Fastingoxidationoffat(mgkg)1min)1) 0.71(cid:2)0.25 0.72(cid:2)0.4
Fastingoxidationofprotein(mgkg)1min)1) 0.73(cid:2)0.33 0.73(cid:2)0.15
Dietaryintake
Caloricintake(kcalday)1) 1835(cid:2)473 1832(cid:2)655
Carbohydrates(%ofdailyenergy) 41.7(cid:2)7.58 42.3(cid:2)8.23
Fats(%ofdailyenergy) 37.94(cid:2)6.46 37.89(cid:2)6.53
ª2011TheAuthors.
DiabeticMedicineª2011DiabetesUK 551
DIABETICMedicine VegetariandietinType2diabetes,arandomizedstudy•H.Kahleovaetal.
Table1 Continued
Characteristic Experimentalgroup(n=37) Controlgroup(n=37)
Proteins(%ofdailyenergy) 20.55(cid:2)4.66 18.42(cid:2)3.31
Fibreintake(gday)1) 22.87(cid:2)7.06 22.95(cid:2)6.51
P⁄Sratio 0.69(cid:2)0.28 0.53(cid:2)0.19
Cholesterolintake(mgday)1) 386(cid:2)181 381(cid:2)224
Qualityoflife
OWLQOLscore 44.85(cid:2)23.69 40(cid:2)20.4
WRSMscore 32.29(cid:2)26.18 30.77(cid:2)18.16
Dataaremeans(cid:2)sd.
DCCT,DiabetesControlandComplicationsTrial;GSH,glutathione;H O ,hydrogenperoxide;HMW,highmolecularweight;hsCRP,
2 2
high-sensitivityC-reactiveprotein;IFCC,InternationalFederationofClinicalChemistryandLaboratoryMedicine;NADPH,nicotinamide
adeninedinucleotidephosphate;OWLQOL,ObesityandWeight-LossQuality-of-Life;P⁄Sratio,ratioofpolyunsaturatedtosaturatedfatty
acids;TBARS,thiobarbituricacidreactivesubstances;WRSM,Weight-RelatedSymptoms.
Studydesign Exerciseprogramme
A24-week,randomized,open,parallel,metabolicallycontrolled Participantswereaskednottoaltertheirexercisehabitsduring
designwasused.Thesubjectswererandomlyassignedtoeither thefirst12weeks.Duringweeks13–24theywereprescribedan
the experimental group (n=37), which received a vegetarian individualized exercise programme based on their history of
diet,orthecontrolgroup(n=37),whichreceivedaconventional physical activity and an initial spiroergometric examination.
diabeticdiet.Bothdietsweredesignedtobeisocaloricandcalorie Participantsexercisedat60%oftheirmaximalheartratetwicea
restricted (-500kcal⁄day), with caloric intakes based on the weekfor1hunderprofessionalsupervision,plusonceaweekat
measurementofrestingenergyexpenditureofeachsubjectby homeoratthesportscentrewiththesameintensity;theywere
indirectcalorimetry(metabolicmonitorVMAX;SensorMedics, givenasport-testerPolarFT4(Polar,Kempele,Finnland)anda
Anaheim,CA,USA)[7].Thesecond12weeksofthedietwere pedometer (Omron HJ-113, Omron, Kyoto, Japan) for
combinedwithaerobicexercise.Allparticipantsstartedwitha individualphysicalactivitiesandwererepeatedlyinstructedon
1-weektutorial,wheretheylearnedindetailhowtocomposeand howtousethem.
prepare their diet. Participants attended weekly 1-h meetings
withlecturesandcookingclasses.Allmealsduringthestudywere
Compliance
provided.Participantswereexaminedatbaseline,12weeksand
24weeks.ThestudyprotocolwasapprovedbytheInstitutional Records of all visits to pick upmeals were kept. At weeks0,
EthicsCommittee. 12 and 24, a 3-day dietary record was completed by each
participant(twoweekdaysandoneweekendday).Aregistered
dietician analysed all 3-day dietary records using a country-
Diet
specificfood-nutrientdatabase[8].Atweeks3,8,14and19,
Thevegetariandiet((cid:3)60%ofenergyfromcarbohydrates,15% a registered dietician made unannounced telephone calls and
proteinand25%fat)consistedofvegetables,grains,legumes, eachparticipantrecalledhisorher24-hdiet.Thisdatasetwas
fruitsandnuts.Animalproductswerelimitedtomaximumof not statistically analysed, but allowed the investigators to
oneportionoflow-fatyogurtaday.Theconventionaldiabetic check the adherence and to provide additional counselling.
dietwasadministeredaccordingtothedietaryguidelinesofthe Participants were divided according to their adherence to the
DiabetesandNutritionStudyGroup(DNSG)oftheEuropean prescribeddietintothehigh,mediumorlowadherencegroup.
AssociationfortheStudyofDiabetes(EASD).Itcontained50% Highadherencewasdefinedastheaveragedailyenergyintake
oftotalenergyfromcarbohydrates,20%protein,lessthan30% being no more than 100kcal in excess of the intake
fat(£7%saturatedfat,<200mg⁄dayofcholesterol⁄day). prescribed; medium adherence was less than 200kcal in
Vegetarianmealswereprovidedintwovegetarianrestaurants excess.Ifcriteriaforneitherhighnormediumadherencewere
andtheconventionaldiabeticdietmealswereprovidedatthe met, the participants were included in the low adherence
Institute for Clinical and Experimental Medicine, Prague. To group. An additional criterion for high adherence to the
meet the vitamin B needs of the experimental group, while vegetarian diet was the average daily cholesterol intake being
12
maintaining the same level of intervention in thetwo groups, £50mgand,formediumadherence,beinglessthan100mg.
vitaminB wassupplementedinboththeexperimentalgroup In the control group, the average daily cholesterol limit was
12
and the control group (50lg⁄day). Alcoholic beverages were £200mg for high adherence and less than 300mg for
limitedtooneperdayforwomenandtwoperdayformen. medium adherence.
ª2011TheAuthors.
552 DiabeticMedicineª2011DiabetesUK
Originalarticle DIABETICMedicine
time⁄echotime(TR⁄TE)=450⁄10msandthicknessof10mm
Physicalactivity
were acquired during breath-hold. The post-processing of
Physical activity was assessed by pedometer Omron HJ-113 magneticresonanceimageswiththecalculationofsubcutane-
(Omron, Kyoto, Japan); each participant completed a 3-day ous and visceral abdominal fat volume was carried out in
record, two weekdays and one weekend day, and with two MATLAB (The Math Works, Natick, MA, USA); the inner
questionnaires: the International Physical Activity Question- border of the subcutaneous region was detected semi-
naire(IPAQ)[9]andtheBaeckequestionnaire[10]atweeks0, automatically [13], while the abdominal fat voxels were
12 and 24. Records of each participant’s visits to the sports selectedbythresholding.
centre were kept. Adherence to the exercise programme was
defined as more than 75% of prescribed visits to the centre
Analyticalmethods
(18⁄24).
Plasma glucose was analysed using the Beckman Analyzer
glucose–oxidasemethod(BeckmanInstrumentsInc.,Fullerton,
Qualityoflife
CA, USA). Plasma immunoreactive insulin and C-peptide
Qualityoflifewasassessedusingtwoquestionnaires:Obesity concentrations were determined using Insulin and C-peptide
and Weight-Loss Quality-of-Life (OWLQOL) and Weight- IRMAkits(Immunotech,Prague,CzechRepublic).HbA was
1c
RelatedSymptoms(WRSM)[11]. measured by HPLC (Tosoh, Tokyo, Japan). Plasma lipid
concentrationsweremeasuredbyenzymaticmethods(Roche).
HDLcholesterolwasmeasuredafterdoubleprecipitationwith
Medication
dextranandmagnesiumchloride.LDLcholesterolwasestimated
Participantswereaskedtocontinuetheirpre-existingmedication usingtheFriedewaldequationiftriglycerideconcentrationwas
regimens, except when hypoglycaemia occurred repeatedly withinnormallimits.
(fasting plasma glucose determined at the laboratory
<4.4mmoll)1 or capillary glucose reading <3.4mmoll)1 Oxidativestressmarkers
accompanied by hypoglycaemic symptoms). In such cases, The amount of lipid peroxidation was determined as
medications were reduced by a study physician following the thiobarbituric acid reactive substances (TBARS) [14] using
medicationprotocol.AllparticipantsweregivenanAccu-Chek home-made kits. The activity of superoxide dismutase,
Goglucometer(Roche,Basel,Switzerland)andwereinstructed catalase,seleno-dependentglutathioneperoxidaseandthelevel
onhowtouseit. of ascorbic acid were analysed by standard methods [15,16]
usingthefollowingkits:superoxidedismutaseassaykit(Sigma-
Aldrich, St Louis, MO, USA), catalase and glutathione
Procedures
peroxidase assay kits (Cayman Chemical, Ann Arbor, MI,
Allmeasurementswereperformedat0,12and24weeksonan USA) and home-made kits for ascorbic acid. Glutathione
outpatientbasis,after10-to12-hovernightfastingwithonlytap reductase activity was measured by the decrease of NADPH
water allowed ad libitum. Height and weight were measured (Sigma-Aldrich).Thewholebloodlevelofreducedglutathione
using a periodically calibrated scale accurate to 0.1kg. Waist wasdeterminedbytheGlutathioneHPLCKitinwholeblood
circumferencewasmeasuredwithatapemeasureplacedatthe (Chromsystems,Munich,Germany).
midpointbetweenthelowestribandtheupperpartoftheiliac
bone. Blood pressure and heart rate were measured after Adipokines
participants had rested in a seated position for 5min using a Plasma concentrations of total adiponectin and resistin were
digital M6 Comfort monitor (Omron, Kyoto, Japan). Three measuredusingELISAkits(Raybiotech,Norcross,GA,USA),
measurements were taken at 2-min intervals. The first high molecular weight (HMW) adiponectin using ELISA kits
measurement was disregarded and a mean value was (Millipore, Billerica, MA, USA) and leptin using Milliplex
calculatedfortheremainingtwomeasurements. (Millipore).
Hyperinsulinaemicisoglycaemicclamp
Statisticalanalyses
Thehyperinsulinaemic(1mUkg)1min)1)isoglycaemicclamp,
lasting3h,wasconductedaspreviouslydescribed[12].Insulin The intention-to-treat analysis included all participants.
sensitivity was estimated as the metabolic clearance rate of Repeated-measures ANOVA models with between-subject
glucose(MCR)calculatedduringthelast20minoftheclamp and within-subject factors and interactions were used for
aftercorrectionforchangesinglucosepoolsize[12]. evaluation of the relationships between continuous variables
andfactors.Factorsgroups,subjectandtime,wereincludedin
Magneticresonanceimaging themodel.Interactionsbetweengroupandtime(group·time)
Twenty-seven water-suppressed magnetic resonance images were calculated for each variable. Within each group, paired
centred to the intervertebral disc of L2⁄L3 with repetition comparisont-testswerecalculatedtotestwhetherthechanges
ª2011TheAuthors.
DiabeticMedicineª2011DiabetesUK 553
DIABETICMedicine VegetariandietinType2diabetes,arandomizedstudy•H.Kahleovaetal.
from baseline to 3months, from baseline to 24weeks and control group, and low among 22.5% in the experimental
from 12 to 24weeks were statistically significant. The v2-test groupand29%inthecontrolgroup.Pedometerreadingsand
was used for evaluation of qualitative variables. Pearson self-reported energy expenditure showed no significant
correlations were calculated for the relationship between between-group differences. Adherence to the prescribed
changes in the metabolic clearance rate of glucose and exercise program was 85.5% (90.3% in the experimental
oxidative stress markers, and changes in volume of groupand80.6%inthecontrolgroup).
visceralfat.Dataarepresentedasmean(cid:2)sdand mean with
95%CI.
Dietaryintake
BaselinedietaryintakeanditschangesareshowninTables1and
Results
2.Bothgroupsreducedenergyintake(P<0.001foreachgroup).
Ninety-two per cent of the participants completed the first Percentage of consumed carbohydrates (out of daily caloric
12weeks (95% in the experimental group and 89% in the intake)increasedintheexperimentalgroup(P=0.002),withno
control group); 84% of the participants in each group change in the control group. Percentage of consumed fats
completed all 24weeks. Adherence to the prescribed diet at decreased in both groups (P=0.03). Percentage of consumed
24weeks was high among 55% participants in the proteins decreased in the experimental group (P<0.001).
experimental group and 32% in the control group, medium Cholesterol intake decreased in the experimental group
among 22.5% in the experimental group and 39% in the (P<0.001)withnochangeinthecontrolgroup.
Table2 Changesinclinicalandlaboratoryvariablesduringthestudy
Experimentalgroup Controlgroup
Change3–0 Change6–0 Change3–0 Change6–0 P-value
BMI(kgm)2) –2.15(cid:2)1.42(cid:2) –2.18(cid:2)2.06(cid:2) –1.21(cid:2)1.46(cid:2) –0.98(cid:2)1.57(cid:2) 0.001
Totalcholesterol(mmoll)1) –0.04(cid:2)0.74 –0.11(cid:2)0.81 0.13(cid:2)0.51 –0.04(cid:2)0.76 0.730
HDLcholesterol(mmoll)1) –0.05(cid:2)0.18 –0.01(cid:2)0.14 0.07(cid:2)0.16 0.08(cid:2)0.14* 0.070
LDLcholesterol(mmoll)1) –0.2(cid:2)0.57* –0.17(cid:2)0.68* –0.16(cid:2)0.48 –0.14(cid:2)0.68 0.050
Homocysteine(lmoll)1) –2.9(cid:2)2.97(cid:2) –4.62(cid:2)3.4(cid:2) –1.49(cid:2)3.09* –3.01(cid:2)2.92(cid:2) 0.170
Triglycerides(mmoll)1) –0.11(cid:2)0.96 –0.27(cid:2)0.92 0.03(cid:2)0.49 0.05(cid:2)0.63 0.120
Freefattyacids(mmoll)1) –0.09(cid:2)0.38 0.09(cid:2)0.66 0.04(cid:2)0.72 0.24(cid:2)0.52* 0.140
Fibrinogen –0.05(cid:2)1.36 –0.51(cid:2)1.1* 0.09(cid:2)0.75 –0.33(cid:2)0.79* 0.490
Fastingplasmaglucose(mmoll)1) –1.45(cid:2)2.2(cid:2) –1.49(cid:2)2.03(cid:2) –1.45(cid:2)2.83(cid:3) –1.05(cid:2)3.2 0.420
Fastingplasmainsulin(nmoll)1) –2.85(cid:2)7.52* –4.07(cid:2)9.12(cid:2) –1.92(cid:2)8.27 –2.93(cid:2)8.75 0.780
FastingplasmaC-peptide(mIUl)1) –0.1(cid:2)0.37 –0.18(cid:2)0.46 –0.21(cid:2)0.34(cid:2) 0(cid:2)1.08 0.750
HbA 1c(DCCT,%) –0.68(cid:2)0.86(cid:2) –0.65(cid:2)0.99(cid:2) –0.59(cid:2)0.89(cid:2) –0.21(cid:2)1.1 0.370
HbA (IFCC,mmol⁄mol) –7(cid:2)9(cid:2) –7(cid:2)10(cid:2) –6(cid:2)9(cid:2) –2(cid:2)11
1c
hsCRP(mgl)1) –1.68(cid:2)3.61* –2.27(cid:2)4.69* –1.41(cid:2)4.53 0.09(cid:2)7.4 0.450
HMWadiponectin(lgml)1) 0.09(cid:2)1.41 0.59(cid:2)1.23* 0.54(cid:2)1.44 0.33(cid:2)1.49 0.050
Catalase(H O min)1mg)1) 282(cid:2)290(cid:2) 203(cid:2)237(cid:2) 185(cid:2)237(cid:2) 118(cid:2)224(cid:3) 0.130
2 2
TBARS(lmoll)1) –0.31(cid:2)0.53(cid:3) –0.66(cid:2)0.54(cid:2) 0.27(cid:2)0.63* –0.56(cid:2)0.62(cid:2) 0.560
Dietaryintake
Caloricintake(kcalday)1) –137(cid:2)477(cid:2) –99(cid:2)438(cid:2) –128(cid:2)641(cid:2) –36.9(cid:2)837(cid:2) 0.13
Carbohydrates(%ofdailyenergy) 5.07(cid:2)9.81* 8.24(cid:2)10.22(cid:3) –0.32(cid:2)9.21 3.15(cid:2)6.78 0.080
Fats(%ofdailyenergy) 1.95(cid:2)2.63 –1.22(cid:2)7.05* 6.2(cid:2)2.77 –1.33(cid:2)5.13* 0.610
Proteins(%ofdailyenergy) –6.87(cid:2)4.52(cid:2) –4.36(cid:2)3.05(cid:2) 0.52(cid:2)4.29 –0.23(cid:2)4.12 <0.001
Fibreintake(gday)1) 6.02(cid:2)9.58* 2.57(cid:2)6.62 1.73(cid:2)9.89 –1.82(cid:2)8.87 0.030
P⁄Sratio 0.74(cid:2)0.55(cid:2) 0.57(cid:2)0.34(cid:2) 0.14(cid:2)0.22* 0.1(cid:2)0.36 0.004
Cholesterolintake(mgday)1) –322(cid:2)224(cid:2) –319(cid:2)206(cid:2) –55.6(cid:2)187 –22.2(cid:2)222 <0.001
Qualityoflife
OWLQOLscore 5.1(cid:2)12* 11.5(cid:2)16(cid:2) 6.5(cid:2)12.7* 7.3(cid:2)14.9* 0.010
WRSMscore –9.9(cid:2)14.8(cid:2) –13(cid:2)20.8(cid:2) –8.1(cid:2)16.9* –8.8(cid:2)17.5* 0.400
Dataaremeans(cid:2)sd.
ListedP-valuesareforinteractionbetweengroupandtimeassessedbyrepeatedmeasuresANOVA.*P<0.05,(cid:3)P<0.01and(cid:2)P<0.001for
within-groupchangesfrombaselineassessedbypairedcomparisont-tests.
DCCT, Diabetes Control and Complications Trial; H O , hydrogen peroxide; HMW, high molecular weight; hsCRP, high-sensitivity
2 2
C-reactiveprotein;IFCC,InternationalFederationofClinicalChemistryandLaboratoryMedicine;OWLQOL,ObesityandWeight-Loss
Quality-of-Life;P⁄Sratio,ratioofpolyunsaturatedtosaturatedfattyacids;TBARS,thiobarbituricacidreactivesubstances;WRSM,Weight-
RelatedSymptoms.
ª2011TheAuthors.
554 DiabeticMedicineª2011DiabetesUK
102
101
100
99
glucose increased in both groups during the first 12weeks
Glycaemiccontrol,insulinsensitivity
(P<0.001 for each group). After exercise, there were
Diabetes medication was reduced in cases of repeated insignificant trends for an increase in the experimental group
hypoglycaemia in 43% of participants in the experimental andadecreaseinthecontrolgroup.Themetabolicclearancerate
groupandin5%ofparticipantsinthecontrolgroup(P<0.001); of glucose increased more in the experimental group from
the difference between groups was 38%(95%CI17–58%). baseline to 24weeks than in the control group [by 30%
HbA fellinbothgroupsduringthefirst12weeks(P<0.001). (95%CI24.5–39) vs. 20% (95%CI14–25); group·time
1c
Itremainedreducedafterexercise.Thedecreasefrombaselineto P=0.04;Fig.2f].
24weeks was significant only in the experimental group
(–0.65(cid:2)1%;P=0.002vs.–0.21(cid:2)1.1%;NSinthecontrol
Bodyweightandabdominalfat
group), however, the difference between groups was not
statistically significant. Among participants whose diabetes Bodyweightdecreasedinbothgroupsinresponsetothedietary
medications remained unchanged, HbA fell by 0.9% in the interventions (P<0.001) and it was maintained after the
1c
experimentalgroupfrombaselineto24weeks(P=0.002)vs.a addition of exercise. Weight loss was greater in the
non-significant decrease of 0.2% in the control group experimental group than in the control group [–6.2kg
(group·time P=0.08). The metabolic clearance rate of (95%CI–6.6 to –5.3) vs. –3.2kg (95%CI–3.7 to –2.5);
gk
(a) Weight (b) Waist circumference (c) LDL cholesterol
EG 116 2.8
CG 114 2.7
2.6
112
98 2.5 110
97
108
96
95 106
94
104 93
92 102
mc 2.4
2.3
2.2
2.1
2
1–l
lomm
Months Months Months
(d) Subcutaneous fat (e) Visceral fat (f) Glucose MCR
8400 4500 3.2
4400
8200 3
4300
8000
4200 2.8
7800 4100
2.6
7600 4000
7400
7200
7000
)lm(
emuloV
3900
3800
3700
3600
)lm(
emuloV
0 3 6 0 3 6 0 3 6
2.4
2.2
2
0 3 6 0 3 6 0 3 6
Months
)1–nim
1–gk
lm(
RCM
Originalarticle DIABETICMedicine
Months Months
FIGURE2 Anthropometricvariables,LDLcholesterol,insulinsensitivity,restingenergyexpenditureandBeckscoreduringthestudy.Experimentalgroup:
closedcircles⁄solidline;controlgroup:opencircles⁄dashedline.Errorbarsrepresent95%CIs.P-valuesforinteractionbetweengroupandtimeassessedby
repeatedmeasuresANOVAareP<0.001forweight(a),P<0.001forwaistcircumference(b),P=0.05forLDLcholesterol(c),P=0.02forsubcutaneous
fat(d)*,p=0.007forvisceralfat(e)*,P=0.04formetabolicclearancerateofglucose(MCR)(f)(cid:3).*Magneticresonanceimagingdatawerenotcompletein15
outofthe74participants:8⁄37intheexperimentalgroup(sixbecauseofdropout,twoasaresultofclaustrophobiaduringthefirstexamination)and7⁄37in
thecontrolgroup(sixbecauseofdropout,oneasaresultofclaustrophobiaduringthefirstexamination).(cid:3)Datafromthehyperinsulinaemicisoglycaemicclamp
werenotcompletein19outofthe74participants:9⁄37intheexperimentalgroup(sixbecauseofdropout,threeasaresultofpatients’fragileveins)and10⁄37
inthecontrolgroup(sixbecauseofdropout,fourasaresultofpatients’fragileveins).
ª2011TheAuthors.
DiabeticMedicineª2011DiabetesUK 555
DIABETICMedicine VegetariandietinType2diabetes,arandomizedstudy•H.Kahleovaetal.
group·time P=0.001; Fig.2a]. Waist circumference also additionofexerciseintheexperimentalgroup,whereasitdid
decreased in both groups in response to the dietary notchangeafterthedietaryinterventionbutincreasedafterthe
interventions(P<0.001),moreintheexperimentalgroupthan additionofexerciseby24%inthecontrolgroup(95%CI+6.3
inthecontrolgroup[–6.4cm(95%CI–7.1to–5.7)vs.–5.3cm to +27.4; P=0.01; group·time P=0.005; Fig.3h). Leptin
(95%CI–5.9to–4.5);group·timeP=0.001].Afterexercise, decreasedsimilarlyinbothgroupsafterthedietaryinterventions,
it further decreased in the experimental group [–1.9 cm butitincreasedaftertheadditionofexerciseinthecontrolgroup.
(95%CI–2.9 to –1.4); P<0.01], whereas it remained Adecreasefrombaselineto24weekswassignificantonlyinthe
unchanged in the control group [+0.7cm (95%CI–0.1 to experimentalgroup[by35%;(95%CI–43to–21.6);P=0.02;
+1.3);NS].Volumeofsubcutaneousfatdecreasedinbothgroups group·timeP=0.05;Fig.3i].
afterthedietaryinterventions(P<0.001).Aftertheadditionof
exercise,itfurtherdecreasedintheexperimentalgroupby2%
Riskfactorsofatherosclerosis
(95%CI–2.9 to –0.7; P<0.05), whereas it insignificantly
increased in the control group by 2% (95%CI–0.1 to +4.2; LDLcholesteroldecreasedby8%afterthedietaryintervention
P=0.06; group·time P=0.02; Fig.2d). The volume of (95%CI–14 to –5; P=0.05) and remained reduced after
visceral fat decreased in both groups after the dietary exerciseintheexperimentalgroup,whileitdidnotchangeinthe
interventions (P<0.001). After the addition of exercise, controlgroup(group·timeP=0.05;Fig.2c).HDLcholesterol
it further decreased in the experimental group by 4% increasedby5%frombaselineto24weeksinthecontrolgroup
(95%CI–5.8to–0.2),whereasitremainedunchangedinthe (95%CI+3.8 to +9; P<0.01). It increased by 6% in the
controlgroup(group·timeP=0.007;Fig.2e). experimental group after exercise training (95%CI+0.2 to
+8.8;P=0.02;group·timeP=0.07).Fibrinogendecreasedin
both groups after exercise training (P=0.02 for the
Oxidativestressmarkers
experimentalgroupandP=0.04forthecontrolgroup).
Plasma concentrations of vitaminC increased by 16%
(95%CI+13.5 to +24.7) after the diet intervention (P=
Qualityoflife
0.002)andremainedelevatedaftertheadditionofexercisein
theexperimentalgroup,whereaschangeswerenotsignificantin Quality of life increased in both groups, but more in the
thecontrolgroup(group·timeP=0.002;Fig.3a).Superoxide experimentalgroup(group·timeP=0.01).
dismutaseincreasedintheexperimentalgroupinsuccessivesteps
by 49% (95%CI+44.7 to +57.4; P<0.001), whereas in the
Regressionanalyses,correlations
controlgroupitgraduallydecreasedby30%(95%CI–50to
–14; P<0.001; group·time P<0.001; Fig.3b). Catalase Regressionanalysesshowedthatchangesinvolumeofvisceralfat
increased in both groups (P<0.01). Thiobarbituric acid werestronglyassociatedwithchangesinthemetabolicclearance
reactive substances decreased in both groups (P<0.001). rateofglucoseandplasmaconcentrationsofenzymaticoxidative
Reduced glutathione increased in the experimental group stressmarkers;eachkilogramoflostvisceralfatwasassociated
graduallyby27%(95%CI+16.8to+29.6;P=0.02;Fig.3c), with increases in the metabolic clearance rate of glucose by
whereas it decreased in the control group by 11% 1.2mlkg)1min)1, superoxide dismutase by 1.7Uml)1 and
(95%CI–19.1 to –0.2; P=0.05; group·time P<0.001). reducedglutathioneby0.9mmoll)1.ThePearson’scorrelation
Glutathione reductase decreased in the experimental group of metabolic clearance rate of glucose change with change in
gradually by 42% (95%CI–52 to –36; P<0.001; Fig.3d), volume of visceral fat was r=–0.63; P<0.001. Correlations
whileglutathioneperoxidaseincreasedinthecontrolgroupby betweenthechangesinthevolumeofvisceralfatandboththe
20%(95%CI+2to+44;P<0.001;Fig.3e)andglutathione changesinsuperoxidedismutaseandreducedglutathionewere
transferaseincreasedinbothgroups,moreinthecontrolgroup r=–0.55;P<0.001andr=–0.45;P=0.02,respectively.
thantheexperimentalgroup[by59%(95%CI+48.5to+69.4)
vs.14%(95%CI+6.3to+24);group·timeP=0.003;Fig.3f].
Discussion
We found that a calorie-restricted vegetarian diet increased
Adipokines
insulinsensitivity,reducedvolumeofvisceralfatandimproved
Plasmaconcentrationsofbothtotalandhigh-molecularweight plasma concentrations of adipokines and oxidative stress
adiponectin increased in the experimental group by 19% markersmorethanaconventionaldietinpatientswithType2
(95%CI+7.5 to +25.4) and 15% (95%CI+3.6 to +23.6), diabetesover24weeks.Theadditionofexercisetrainingfurther
respectively,frombaselineto24weeks,whileitdidnotchange augmented the improved outcomes with our vegetarian diet.
significantly in the control group (group·time P=0.02; To the best of our knowledge, this is the first study that has
Fig.3g, Table2 and group·time P=0.05, respectively). elucidatedtheeffectofavegetariandietandavegetariandietplus
Resistin decreased after the dietary intervention by 19% exercise on these variables.. The advantageous effects of a
(95%CI–25.7 to –10.2) and remained reduced after the vegetariandietmaybepartlyexplainedbyweightloss,especially
ª2011TheAuthors.
556 DiabeticMedicineª2011DiabetesUK
120 EG 8 4
CG
7 3.5
100
6 3
80
5 2.5
60 4 2
40
20
0
loss of visceral fat and the consequent increase in insulin ofsaturatedfat[andahigherpolyunsaturatedandsaturatedfatty
sensitivity. acid (P⁄S) ratio] [19], higher intake of non-heme iron and
Severalpossiblemechanismsmayexplainthebeneficialeffects reductioninironstores[20],higherintakeofvegetableproteinin
ofavegetariandiet[17]:higherintakeoffibre[18],lowerintake placeofanimalprotein[21],higherintakeofantioxidants[22]
1–l
lomμ
3
2
1
0
1–lm
U
1.5
1
0.5
0
1–l
lomm
(a) Vitamin C (b) Superoxide dismutase (c) Reduced glutathione
Months Months Months
(d) Glutathione reductase (e) Glutathione peroxidase (f) Glutathione transferase
350 800
70
300
750 60
250
200
150
100
1–lm1
nim
HPDAN
lomμ
700
650
600
550
1–lm1–nim
HSG
lomμ
50
40
30
20
1–lm1–nim
HSG
lomμ
0 3 6 0 3 6 0 3 6
50 550 10
0 500 0
0 3 6 0 3 6 0 3 6
Months Months Months
(g) Adiponectin (h) Resistin (i) Leptin
8.5 13 1100
1050
8 12
1000
950
7.5 11
900
7
6.5
6
5.5
0 3 6 0 3 6 0 3 6
Months Months Months
1–lm
gμ
850
800
750
700
650
600
Mp 10
9
8
7
1–lm
gn
Originalarticle DIABETICMedicine
FIGURE3 Plasmalevelsofoxidativestressmarkersandadipokinesduringthestudy.Experimentalgroup:closedcircles⁄solidline;controlgroup:open
circles⁄dashedline.Errorbarsrepresent95%CIs.P-valuesforinteractionbetweengroupandtimeassessedbyrepeatedmeasuresANOVAareP=0.002for
VitaminC(a),P<0.001forsuperoxidedismutase(b),P<0.001forreducedglutathione(c),P<0.001forglutathionereductase(d),P=0.004for
glutathioneperoxidase(e),P=0.003forglutathionetransferase(f),P=0.02foradiponectin(g),P=0.005forresistin(h)andP=0.05forleptin(i).GSH,
glutathione;NADPH,nicotinamideadeninedinucleotidephosphate.
ª2011TheAuthors.
DiabeticMedicineª2011DiabetesUK 557
DIABETICMedicine VegetariandietinType2diabetes,arandomizedstudy•H.Kahleovaetal.
andplantsterols[23].Avegetariandietwasreportedtoreduce markersthanaconventionaldiabeticdietwithorwithoutthe
intramyocellularlipidconcentrations[24]andthis,togetherwith additionofexercise.Vegetariandietsmayprovideabeneficial
theeffectonvisceralfatwhichweobserved,mightberesponsible alternativefornutritionaltherapyinType2diabetes,especially
for a substantial portion of the effect of a vegetarian diet on in combination with aerobic exercise. Further studies should
insulinsensitivityandenzymaticoxidativestressmarkers. explore the precise mechanisms and long-term effects of
Our data suggest that a vegetarian diet leads to a complex vegetariandietsinpatientswithType2diabetes.
improvementofenzymaticandnon-enzymaticoxidativestress
markers. Both enzymatic and non-enzymatic antioxidant
Competing interests
defencemechanismsworkinsynergyagainstdifferenttypesof
freeradicals[25],whichplayamajorroleinthedevelopmentand Nothingtodeclare.
progressionofdiabetesanditscomplications[26].Thechanges
weobservedinplasmaconcentrationsofadipokinesreflectloss
Acknowledgements
ofadiposetissue.
The reduction in LDL cholesterol observed with our This work was supported by grant IGA MZCR NS⁄10534-3
vegetarian diet is in concordance with previousstudies where from Ministry of Health, Prague, Czech Republic. We thank
vegetariandietshavebeenshowntoreduceLDLcholesterol[4] the 74 participants for their cooperation, as well as all
and postprandial lipids [27] and to reverse atherosclerosis physicians,registereddieticiansandnursesfortheirinvaluable
progression [28]. Of interest is the different dynamics of contributions. Special thanks to Thomas O’Hearn, Fariba
changes in HDL cholesterol (although the difference between Shojaee-MoradieandJohnSievenpiperforgreathelpwithtext
groupswasnotsignificant):whereasitincreasedinthecontrol corrections.
groupfrombaselineto6monthswithnosignificantincreasein
eitherperiod,itincreasedintheexperimentalgrouponlyafterthe
References
additionofexercise.Previousstudieshaveshownnoincreaseor
even a decrease in HDL cholesterol with vegetarian diets; 1 Tonstad S, Butler T, Yan R, Fraser GE. Type of vegetarian diet,
however,thisdecreaseislessthanthatseenwithLDLcholesterol. body weight, and prevalence of Type2 diabetes. Diabetes Care
2009;32:791–796.
IsolatedincreasesinHDLcholesterolobservedinotherdietsdo
2 Snowdon DA, Phillips RL. Does a vegetarian diet reduce the
notconferthesamebenefits[29].
occurrenceofdiabetes?AmJPublicHealth1985;75:507–512.
Thestrengthsofourstudyincludetheparalleldesign,inwhich 3 NicholsonAS,SklarM,BarnardND,GoreS,SullivanR,Browning
allparticipantsstartedsimultaneously,allowingtheinvestigators S. Toward improved management of NIDDM: a randomized,
to use weekly meetings in both groups to encourage further controlled, pilot intervention using a low-fat, vegetarian diet.
PrevMed1999;29:87–91.
compliance. Providing all meals for the participants and
4 BarnardND,CohenJ,JenkinsDJA,Turnier-McGrievyG,GloedeL,
exercising under professional supervision ensured the best
JasterBetal.Alow-fatvegandietimprovesglycemiccontroland
possible compliance. The study duration was long enough to cardiovascularriskfactorsinarandomizedclinicaltrialinindivid-
allow sufficient time for adaptation to the diet. The study ualswithtype2diabetes.DiabetesCare2006;29:1777–1783.
investigated several metabolic variables, with the results 5 BarnardND,CohenJ,JenkinsDJA,Turnier-McGrievyG,GloedeL,
GreenAetal.Alow-fatvegandietandaconventionaldiabetesdiet
applicableoutsideoftheresearchsetting.
in the treatment of type2 diabetes: a randomized, controlled,
Weareawareofseverallimitationsofourstudy.Thenumber
74-weekclinicaltrial.AmJClinNutr2009;89:1588S–1596S.
of subjects did not provide sufficient power to confirm the 6 Dube´ JJ, Amati F, Stefanovic-Racic M, Toledo FGS, Sauers SE,
superioreffectofthevegetariandietonHbA ,asobservedby Goodpaster BH. Exercise-induced alterations in intramyocellular
1c
Barnardetal.[4].Loweradherencetotheprescribeddietinthe lipids and insulin resistance: the athlete’s paradox revisited. Am
JPhysiolEndocrinolMetab2008;294:E882–888.
controlgroupaftertheadditionofexercisepointstoapotential
7 FerranniniE.Thetheoreticalbasesofindirectcalorimetry:areview.
weaknessofthe conventionaldiabeticdiet:portionsize limits
Metabolism1998;37:287–301.
mayhaveincreasedfeelingsofhungerduringexercise,leading 8 Mullerova D, Tychtl Z, Muller L, Brazdova Z. NutriDan 1.2.
subjectstoexceedtheirprescribedenergyintakelimits. Prague,CzechRepublic:DanoneInstitute,2003.
The limited adherence to theconventionaldiabetic diet has 9 Hagstro¨mer M, Oja P, Sjo¨stro¨m M. The International Physical
ActivityQuestionnaire(IPAQ):astudyofconcurrentandconstruct
beenawell-documentedproblemindietaryinterventionstudies
validity.PublicHealthNutr2006;9:755–762.
[4,30].Especiallyduringexercise,itbecameevidentinourtrial
10 Baecke JA, Burema J, Frijters JE. A short questionnaire for the
thatitwaseasierforsubjectstofollowavegetariandietthana measurementofhabitualphysicalactivityinepidemiologicalstud-
conventional diabetic diet. This may be partly responsible for ies.AmJClinNutr1982;36:936–942.
the greater reduction in volume of visceral fat and insulin 11 PatrickDL,BushnellDM,RothmanM.Performanceoftwoself-
report measures for evaluating obesity and weight loss. Obesity
resistancewiththevegetariandietafteraerobicexercise.
2004;12:48–57.
Inconclusion,ourresultsindicatethatavegetariandietalone
12 Pelika´nova´ T,Smrckova´ I,Krı´zova´ J,Strı´brna´ J,La´nska´ V.Effects
orincombinationwithexerciseismoreeffectiveinincreasing of insulin and lipid emulsion on renal haemodynamics and renal
insulinsensitivity,reducingvolumeofvisceralfatandimproving sodiumhandlinginIDDMpatients.Diabetologia1996;39:1074–
plasma concentrations of adipokines and oxidative stress 1082.
ª2011TheAuthors.
558 DiabeticMedicineª2011DiabetesUK
Originalarticle DIABETICMedicine
13 ChabiniokR,TinteˇraJProceedingsofCzechJapaneseSeminarin 23 Strandberg TE, Gylling H, Tilvis RS, Miettinen TA. Serum plant
AppliedMathematics2006,FacultyofMathematics,KyushuUni- and other non-cholesterol sterols, cholesterol metabolism and
versity,Fukuoka,Japan,14–17September2006:37–49. 22-year mortality among middle-aged men. Atherosclerosis 2010;
14 YokodeM,KitaT,KikawaY,OgorochiT,NarumiyaS,KawaiC. 210:282–287.
Stimulatedarachidonatemetabolismduringfoamcelltransforma- 24 GoffLM,BellJD,SoP,DornhorstA,FrostGS.Veganismandits
tion of mouse peritoneal macrophages with oxidized low density relationshipwithinsulinresistanceandintramyocellularlipid.Eur
lipoprotein.JClinInvest1988;81:720–729. JClinNutr2005;59:291–298.
15 Concetti A, Massei P, Rotilio G, Brunori M, Rachmilewitz EA. 25 Maritim AC,Sanders RA,Watkins JB.Diabetes, oxidative stress,
Superoxide dismutase in red blood cells: method of assay and and antioxidants: a review. J Biochem Mol Toxicol 2003; 17:
enzymecontentinnormalsubjectsandinpatientswithb-thalasse- 24–38.
mia(majorandintermedia).JLabClinMed1976;87:1057–1064. 26 ForbesJM,CoughlanMT,CooperME.Oxidativestressasamajor
16 Nakagawa K, Kanno H, Miura Y. Detection and analyses of culprit in kidney disease in diabetes. Diabetes 2008; 57: 1446–
ascorbyl radical in cerebrospinal fluid and serum of acute lym- 1454.
phoblasticleukemia.AnalBiochem1997;254:31–35. 27 DeNataleC,AnnuzziG,BozzettoL,MazzarellaR,CostabileG,
17 BarnardND,KatcherHI,JenkinsDJ,CohenJ,Turner-McGrievy CianoOetal.Effectsofaplant-basedhigh-carbohydrate⁄high-fiber
G.Vegetarianandvegandietsintype2diabetesmanagement.Nutr diet versus high-monounsaturated fat⁄low-carbohydrate diet on
Rev2009;67:255–263. postprandiallipidsintype2diabeticpatients.DiabetesCare2009;
18 ChandaliaM,GargA,LutjohannD,vonBergmannK,GrundySM, 32:2168–2173.
BrinkleyLJ.Beneficialeffectsofhighdietaryfiberintakeinpatients 28 OrnishD,BrownSE,ScherwitzLW,BillingsJH,ArmstrongWT,
withtype2diabetesmellitus.NEnglJMed2000;342:1392–1398. PortsTAetal.Canlifestylechangesreversecoronaryheartdisease?
19 RiccardiG,GiaccoR,RivelleseAA.Dietaryfat,insulinsensitivity TheLifestyleHeartTrialLancet1990;336:129–133.
andthemetabolicsyndrome.ClinNutr2004;23:447–456. 29 OrnishD.WasDrAtkinsright?JAmDietAssoc2004;104:537–
20 CookJD.Adaptationinironmetabolism.AmJClinNutr1990;51: 542.
301–308. 30 LaitinenJH,AholaIE,SarkkinenES,WinbergRL,Harmaakorpi-
21 AndersonJW,SmithBM,WashnockCS.Cardiovascularandrenal IivonenPA,UusitupaMI.Impactofintensifieddietarytherapyon
benefitsofdrybeanandsoybeanintake.AmJClinNutr1999;70: energy and nutrient intakes and fatty acid composition of serum
464S–474S. lipids in patients with recently diagnosed non-insulin-dependent
22 BlomhoffR.Dietaryantioxidantsandcardiovasculardisease.Curr diabetesmellitus.JAmDietAssoc1993;93:276–283.
OpinLipidol2005;16:47–54.
ª2011TheAuthors.
DiabeticMedicineª2011DiabetesUK 559
